All news

An officer proposes selling 1,482 Twist Bioscience (TWST) shares, including shares to cover taxes.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Robert F. Werner, an officer at Twist Bioscience Corp. (TWST), has proposed selling 1,482 common shares with an aggregate market value of $279,925.79, primarily to cover tax obligations from a vested equity award distribution. The shares were acquired through restricted stock vesting on October 1, 2026, with the approximate sale date set for October 2, 2026, through Fidelity Brokerage Services LLC. This Form 144 filing indicates a neutral impact and sentiment, as it is a routine sale to manage tax liabilities associated with equity compensation.

Read original source

TWST company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.